Pol theta inhibitor ART4215
Term · Oncology and biomedicine · MLC-T-ONC-016135
An orally bioavailable and selective inhibitor of DNA polymerase (pol) theta, with potential chemosensitizing and antineoplastic activities. Upon oral administration, Pol theta inhibitor ART4215 targets, binds to and inhibits the activity of pol theta. This prevents pol theta-mediated repair of damaged DNA and may have a synergistic effect if administered in combination with agents that cause DNA damage. Pol theta plays a key role in DNA synthesis and repair.
| Identifier | MLC-T-ONC-016135 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | DNA polymerase theta inhibitor ART4215 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016135",
"term": "Pol theta inhibitor ART4215",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable and selective inhibitor of DNA polymerase (pol) theta, with potential chemosensitizing and antineoplastic activities. Upon oral administration, Pol theta inhibitor ART4215 targets, binds to and inhibits the activity of pol theta. This prevents pol theta-mediated repair of damaged DNA and may have a synergistic effect if administered in combination with agents that cause DNA damage. Pol theta plays a key role in DNA synthesis and repair.",
"synonyms": [
"DNA polymerase theta inhibitor ART4215"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/pol-theta-inhibitor-art4215/"
}
Record 13,407 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.